B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Neuroscience
May 21, 2013 |
4.9 / 5 (16) |
0
|
Diabetes drug tested in Parkinson's disease patients
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...
Parkinson's & Movement disorders
May 20, 2013 |
not rated yet |
0
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS
May 19, 2013 |
5 / 5 (1) |
0
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Psychology & Psychiatry
May 19, 2013 |
4.9 / 5 (7) |
1
|
World first clinical trial supports use of Kava to treat anxiety
(Medical Xpress)—A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.
Psychology & Psychiatry
May 13, 2013 |
5 / 5 (2) |
1
Palivizumab cuts number of days of wheezing in preemies
(HealthDay)—Many pre-term babies suffer recurrent episodes of wheezing. Now, researchers say a common infection is a likely culprit and they may be able to prevent the breathing problems.
Diseases, Conditions, Syndromes
May 09, 2013 |
not rated yet |
0
|
Ambrisentan not effective in idiopathic pulmonary fibrosis
(HealthDay)—The endothelin A receptor-selective antagonist ambrisentan is not effective for reducing the rate of idiopathic pulmonary fibrosis (IPF) progression, according to a study published in the May ...
Diseases, Conditions, Syndromes
May 07, 2013 |
not rated yet |
0
Drugs can cut breast cancer risk for some, task force finds
(HealthDay)—The drugs tamoxifen and raloxifene (Evista) could reduce the risk of breast cancer among women who are at high risk of developing the disease, a new report confirms.
Cancer
Apr 16, 2013 |
not rated yet |
0
Topical anesthetics effective for premature ejaculation
(HealthDay)—Topical anesthetic agents seem to be effective and are generally well tolerated for patients with premature ejaculation (PE), according to a review published in the April issue of Urology.
Diseases, Conditions, Syndromes
Apr 12, 2013 |
5 / 5 (1) |
0
Azithromycin may provide benefit for treatment of respiratory disorder
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic azithromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a ...
Diseases, Conditions, Syndromes
Mar 26, 2013 |
not rated yet |
0
Antibiotic may provide benefit for treatment of respiratory disorder
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a ...
Diseases, Conditions, Syndromes
Mar 26, 2013 |
not rated yet |
0
|
Supplement aids age-related macular degeneration
(HealthDay)—A supplement containing a combination of lutein, zeaxanthin, and ω-3 long-chain polyunsaturated fatty acids (LC-PUFAs) significantly benefits patients with age-related macular degeneration ...
Ophthalmology
Mar 26, 2013 |
5 / 5 (2) |
0
Drug may ease angina in people with type 2 diabetes
(HealthDay)—The drug Ranexa (ranolazine) may help reduce chest pain in people with type 2 diabetes, a new study finds.
Diabetes
Mar 11, 2013 |
5 / 5 (2) |
0
Study shows anemia drug does not improve health of anemic heart failure patients
Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients –darbepoetin alfa – does not improve patients' health, ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Study shows mirabegron effective and well tolerated for overactive bladder
In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with ...
Diseases, Conditions, Syndromes
Mar 04, 2013 |
not rated yet |
0
